Other trials also include detecting the expression of lncRNAs like CCAT1 and HOTAIR in CRC patients25, HOTAIR in thyroid cancer26 and in general using lncRNAs as biomarkers for the detection/prognosis of several other cancer types including lung cancer (NCT03830619), ovarian cancer (NCT03738319) and triple negative breast cancer (NCT02641847). This evidence concerns the gene HOTAIR and colorectal carcinoma.